Corbevax, Covovax, Anti-Viral Drug Molnupiravir Approved by Drug Regulator CDSCO

Central Drug Authority CDSCO has approved the Serum Institute of India's COVID-19 vaccine Covovax, Biological E's jab Corbevax and anti-Covid pill Molnupiravir for restricted use in emergency situation.

Drug regulator CDSCO approves vaccines Corbevax, Covovax, anti-viral drug Molnupiravir for restricted emergency use against COVID-19

— Press Trust of India (@PTI_News) December 28, 2021

Health Minister Dr Mansukh Mandaviya Congratulates India:

Congratulations India 🇮🇳

Further strengthening the fight against COVID-19, CDSCO, @MoHFW_INDIA has given 3 approvals in a single day for:

- CORBEVAX vaccine

- COVOVAX vaccine

- Anti-viral drug Molnupiravir

For restricted use in emergency situation. (1/5)

— Dr Mansukh Mandaviya (@mansukhmandviya) December 28, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)